免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Simplexa 肠炎弧菌直接检测;Simplexa 肠炎弧菌阳性对照包

K号: K163085 · 2017-02-14

决定日期2017-02-14
产品代码OZN
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack is the device name listed in this FDA 510(k) record. The listed applicant is Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC. It received FDA 510(k) clearance on 2017-02-14 under 510(k) number K163085. The device is classified under product code OZN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?

Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack is a medical device that received FDA 510(k) clearance on 2017-02-14. The listed applicant is Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC. The 510(k) number is K163085.

When did Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack receive FDA 510(k) clearance?

Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack received FDA 510(k) clearance on 2017-02-14, under 510(k) number K163085.

Who is the listed applicant for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?

The FDA 510(k) record lists Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?

The FDA product code for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack is OZN.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:OZN)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑